Aumolertinib as adjuvant therapy in resected EGFR-mutated non-small-cell lung cancer (ARTS): a double-blind, multicentre, randomised, controlled, phase 3 trial

The Lancet Oncology 2026

View at publisher
Authors: Liang Zhang, XiQin Zhang, Lin Wu, Wenqun Xing, Chunling Liu, Peng Zhang, Kai Chen, Jianhua Shi, Shidong Xu, Xiaodong Zhang, Xiaorong Dong, Haohui Fang
+7 more Xinmin Yu, Yang Gao, Gaofeng Li, Zhenming Chen, Shaonan Fan, Xiaoqing Zhang, Ying Cheng
DOI: 10.1016/s1470-2045(25)00643-6
Cited by: 8
References: 19

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Lung Cancer Research Studies Lung Cancer Diagnosis and Treatment

Publication details

Journal / source
The Lancet Oncology
Publisher
Elsevier BV
Volume
27
Issue
2
Pages
159–168
Publication date
12 January 2026
Language
EN